Home /

Solutions /

Custom

DeepMirror Bio for BioPharma R&D and Diagnostics

DeepMirror Bio is the one stop solution for digital R&D that predicts biomolecular properties and can easily be refined with in-house data. The platform is explainable and identifies structures of interest (see Technology section). We also offer DeepMirror Image: a micro service that is used to build automated image analysis pipelines for Target Discovery and preclinical work.

Small Molecules
Oligos
Antibodies & Peptides

Supported Workflows

OIligo Assays

In RNA assays, researchers measure properties of RNA (such as mRNA or siRNA) to find optimal sequences that can have therapeutic value. Using DeepMirror Bio, they can identify the most relevant candidates to synthesise and de-risk drug discovery.

Small Molecule Assays

In Small Molecule Assays, researchers measure molecule properties (such as ADME and target binding) to find optimal candidates to move into the clinic. Using DeepMirror Bio, they can identify the most relevant candidates to synthesise and de-risk drug discovery.

High Content Imaging

In High Content Imaging researchers use large amounts of microscopy data to reach conclusions about, for example, the efficacy of a drug or the diagnosis of a diesease. Using DeepMirror Image, we can build automated image analysis pipelines 5x faster than other platforms due to less data requirements.

Protein Assays

In protein assays, researchers measure properties of protein such as peptides and antibodies to find new medicines. Using DeepMirror Bio, they predict protein properties from a few measured datapoints to identify optimal amino acid sequences with high therapeutic value.